Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.51M

combined est. value

Stock	Shares	Price	Value	Weight	As of
TRDAEntrada Therapeutics, Inc.	213,598	$7.06	$1.51M	100%	2026-03-03

TRDA

Entrada Therapeutics, Inc.

$1.51M

213,598 sh

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 0sells 0

Stock	Transaction	Date	~6mo later
TRDAEntrada Therapeutics, Inc.	Tax $165.0K · 14,038 sh	2026-03-03	—
TRDAEntrada Therapeutics, Inc.	Tax $84.2K · 7,223 sh	2026-03-02	—
TRDAEntrada Therapeutics, Inc.	Grant — · 55,800 sh	2026-03-01	—
TRDAEntrada Therapeutics, Inc.	Tax $9.5K · 1,746 sh	2025-09-02	—

TRDATax

2026-03-03 · Entrada Therapeutics, Inc.

$165.0K

—

TRDATax

2026-03-02 · Entrada Therapeutics, Inc.

$84.2K

—

TRDAGrant

2026-03-01 · Entrada Therapeutics, Inc.

55,800

—

TRDATax

2025-09-02 · Entrada Therapeutics, Inc.

$9.5K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.